Treatment of menstrual migraine with sequential, transdermal, 17-beta-estradiol. A double-blind, randomised, cross-over trial

Trial Profile

Treatment of menstrual migraine with sequential, transdermal, 17-beta-estradiol. A double-blind, randomised, cross-over trial

Completed
Phase of Trial: Phase II/III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Estradiol (Primary)
  • Indications Menstrual migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2011 Status changed from active, no longer recruiting to completed.
    • 23 Jun 2011 Primary endpoint 'Headache-attacks' has not been met.
    • 23 Jun 2011 Results published in Fertility and Sterility.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top